SOURCE: The Bedford Report

The Bedford Report

April 19, 2010 16:45 ET

Complimentary Analyst Research on International Business Machines Corp. (NYSE: IBM), Pfizer, Inc. (NYSE: PFE), UAL Corp. (NASDAQ: UAUA), DryShips, Inc. (NASDAQ: DRYS) and Many More Available at

Note to Editors: The Following Is an Investment Opinion Being Issued by The Bedford Report

TORONTO--(Marketwire - April 19, 2010) -  The Bedford Report is pleased to announce that its latest Market Update analyzing recent news and events on International Business Machines Corp. (NYSE: IBM), Pfizer, Inc. (NYSE: PFE), UAL Corp. (NASDAQ: UAUA) and DryShips, Inc. (NASDAQ: DRYS) has been released.

In this issue of The Bedford Report we will release our analysis of IBM's fiscal first quarter earnings report immediately following the company's earnings call. We also look at projected losses for UAL subsidiary, United, following the closure of most European airports and we look at DryShips' growth potential. And after Eli Lilly & Co cut its full-year profit forecast due to the newly passed U.S. healthcare overhaul, we predict what type of guidance to expect from Pfizer. There is much more analysis regarding these companies and many more available at

Our updated analyst reports on IBM, Pfizer, UAL and DryShips include:
-- An unbiased view and rating of the company
-- Recent key developments
-- Solid analyst summary -- who's saying what and why?
-- In-depth industry analysis and outlook
-- Major upcoming events to watch out for

Take the few minutes to register with us at and get access to numerous company reports and industry newsletters and stay abreast of market highlights so you can make the best investment decisions at the right time. Like you, we realize that timing is everything and so we only put out updates and analysis when the markets are ripe for immediate action. has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.

Please view the full disclaimer:

Contact Information